BLCO logo

Bausch + Lomb Corporation (BLCO)

Profile

Full Name

Bausch + Lomb Corporation

Ticker

NYSE: BLCO

Exchange

NYSE

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

Canada

IPO

May 6, 2022

Indexes

Not included

Website

http://www.bausch.com

Employees

13500

Key Details

Price

$14.32(+2.51%)

Market cap

$5.06B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4.79B(+15.56% YoY)

Annual EPS

-$0.90(-21.62% YoY)

PE ratio

-

Next earnings date

Jul 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $14.32
    BLCO price is $14.32

    30-Day Relative Volume

    2.27
    BLCO 30-day relative volume is 2.27

    Price Performance

    Price Most recent change

    +2.51%
    BLCO price was up +2.51% on Jul 25, 2025

    Price YTD change

    -20.71%
    BLCO price is down -20.71% since January 1st

    Price 1-year change

    -7.79%
    BLCO price is down -7.79% year-on-year

    Price 3-year change

    -11%
    BLCO price is down -11% over the past 3 years

    Price Range

    Price All-time high

    $21.95
    BLCO price is currently -34.76% below its historical high of $21.95

    Price 3-year low

    $10.45
    BLCO price is currently +37.03% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $5.06B
    BLCO market capitalization is $5.06 billion

    Market cap 3-year change

    -10.14%
    BLCO market capitalization is down -10.14% over the past 3 years

    Market cap All-time high

    $7.51B
    BLCO market capitalization is currently -32.60% below its historical high of $7.51 billion

    Market cap sector rank

    89.04%
    BLCO market capitalization is higher than 89.04% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.43%
    BLCO shares outstanding is up +0.43% year-on-year

    Shares Outstanding 3-Year Change

    +0.97%
    BLCO shares outstanding is up +0.97% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.19
    BLCO beta is 1.19

    200-day SMA

    $15.78
    BLCO price is currently -9.25% below its 200-day simple moving average

    50-day SMA

    $12.61
    BLCO price is currently +13.58% above its 50-day simple moving average

    RSI

    64.53
    BLCO 14-day relative strength index is 64.53

    Volume

    2.27
    BLCO 30-day relative volume is 2.27

    ATR

    $0.43
    BLCO average true range is $0.43

    10-day Historical Volatility

    28.00%
    BLCO 10-day historical volatility is 28.00%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $4.79B
    BLCO annual revenue is $4.79 billion

    Revenue Analysts estimate

    $5.03B
    BLCO annual revenue is currently -4.77% lower than the consensus analysts' forecast

    Revenue 1-year change

    +15.56%
    BLCO annual revenue is up +15.56% year-on-year

    Revenue Sector rank

    91.66%
    BLCO annual revenue is higher than 91.66% of companies in Healthcare sector

    EPS

    EPS

    -$0.90
    BLCO annual earnings per share is -$0.90

    EPS Analysts estimate

    $0.46
    BLCO annual earnings per share is currently -295.52% lower than the consensus analysts' forecast

    EPS 1-year change

    -21.62%
    BLCO annual earnings per share is down -21.62% year-on-year

    EPS Sector rank

    58.09%
    BLCO annual earnings per share is higher than 58.09% of companies in Healthcare sector

    Profit

    Gross profit

    $2.92B
    BLCO annual gross profit is $2.92 billion

    Gross margin

    60.93%
    BLCO annual gross profit margin is 60.93%

    Operating profit

    $188.00M
    BLCO annual operating income is $188.00 million

    Operating margin

    3.92%
    BLCO annual operating profit margin is 3.92%

    Net income

    -$317.00M
    BLCO annual net profit is -$317.00 million

    Net margin

    -6.62%
    BLCO annual net profit margin is -6.62%

    Expenses

    Total expenses

    $4.60B
    BLCO annual total expenses is $4.60 billion

    Operating expenses

    $2.73B
    BLCO annual total operating expenses is $2.73 billion

    Cost of goods sold

    $1.87B
    BLCO annual cost of goods sold is $1.87 billion

    Selling, general & administrative expenses

    $2.08B
    BLCO annual SGA is $2.08 billion

    Depreciation and amortization

    $436.00M
    BLCO annual depreciation & amortization is $436.00 million

    Interest expense

    $399.00M
    BLCO annual interest expense is $399.00 million

    Income tax

    $71.00M
    BLCO annual income tax is $71.00 million

    EBIT & EBITDA

    EBIT

    $165.00M
    BLCO annual earnings before interest & taxes is $165.00 million

    EBITDA

    $601.00M
    BLCO annual EBITDA is $601.00 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $13.47B
    BLCO annual total assets is $13.47 billion

    Non current assets

    $10.68B
    BLCO annual long term assets is $10.68 billion

    Current assets

    $2.79B
    BLCO annual total current assets is $2.79 billion

    Cash and cash equivalents

    $305.00M
    BLCO annual cash & cash equivalents is $305.00 million

    Accounts receivable

    $1.03B
    BLCO annual accounts receivable is $1.03 billion

    Inventory

    $1.04B
    BLCO annual inventory is $1.04 billion

    Liabilities

    Total liabilities

    $6.92B
    BLCO annual total liabilities is $6.92 billion

    Long term liabilities

    $5.19B
    BLCO annual total long term liabilities is $5.19 billion

    Current liabilities

    $1.74B
    BLCO annual total current liabilities is $1.74 billion

    Accounts payable

    $389.00M
    BLCO annual accounts payable is $389.00 million

    Debt

    Total debt

    $4.78B
    BLCO annual total debt is $4.78 billion

    Total debt 1-year change

    +4.87%
    BLCO annual total debt is up +4.87% year-on-year

    Long term debt

    $4.74B
    BLCO annual long term debt is $4.74 billion

    Short term debt

    $40.00M
    BLCO annual short term debt is $40.00 million

    Equity & Capital

    Shareholders equity

    $6.47B
    BLCO annual stockholders equity is $6.47 billion

    Book value

    $6.47B
    BLCO annual book value is $6.47 billion

    Retained earnings

    -$571.00M
    BLCO annual retained earnings is -$571.00 million

    Working capital

    $1.05B
    BLCO annual working capital is $1.05 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $232.00M
    BLCO annual cash flow from operations is $232.00 million

    Cash from operations 1-year change

    +1464.71%
    BLCO annual cash flow from operations is up +1464.71% year-on-year

    Cash from investing

    -$412.00M
    BLCO annual cash flow from investing activities is -$412.00 million

    Cash from investing 1-year change

    +80.46%
    BLCO annual cash flow from investing activities is up +80.46% year-on-year

    Cash from financing

    $178.00M
    BLCO annual cash flow from financing activities is $178.00 million

    Cash from financing 1-year change

    -91.43%
    BLCO annual cash flow from financing activities is down -91.43% year-on-year

    CAPEX

    CAPEX

    $291.00M
    BLCO annual capital expenditures is $291.00 million

    CAPEX 1-year change

    +60.77%
    BLCO annual capital expenditures is up +60.77% year-on-year

    Free Cash Flow

    Free cash flow

    -$59.00M
    BLCO annual free cash flow is -$59.00 million

    Free cash flow 1-year change

    +70.2%
    BLCO annual free cash flow is up +70.2% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    60.93%
    BLCO annual gross profit margin is 60.93%

    Operating margin

    3.92%
    BLCO annual operating profit margin is 3.92%

    Net margin

    -6.62%
    BLCO annual net profit margin is -6.62%

    ROA & ROE

    ROA

    -2.36%
    BLCO annual return on assets is -2.36%

    ROE

    -4.71%
    BLCO annual return on equity is -4.71%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BLCO price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BLCO price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.80
    BLCO price to book ratio is 0.80

    PB ratio Sector rank

    32.51%
    BLCO price to book ratio is higher than 32.51% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.05
    BLCO price to sales ratio is 1.05

    PS ratio Sector rank

    24.13%
    BLCO price to sales ratio is higher than 24.13% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $9.69B
    BLCO enterprise value is $9.69 billion

    Enterprise value Sector rank

    91.49%
    BLCO enterprise value is higher than 91.49% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    19.30
    BLCO EV/EBITDA is 19.30

    EV/EBITDA Sector rank

    91.46%
    BLCO EV/EBITDA is higher than 91.46% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.60
    BLCO annual current ratio is 1.60

    Quick ratio

    1.01
    BLCO annual quick ratio is 1.01

    Leverage

    Debt to equity

    0.74
    BLCO annual debt to equity ratio is 0.74

    Interest coverage ratio

    0.41
    BLCO annual interest coverage ratio is 0.41

    Risk & Stability

    Piotroski F-Score

    3
    BLCO piotroski f-score is 3

    Altman Z-Score

    0.87
    BLCO altman z-score is 0.87

    Analyst ratings

    Recent major analysts updates

    Jul 9, 25 Citigroup
    Neutral
    Jul 8, 25 Evercore ISI Group
    Outperform
    Jun 9, 25 Barclays
    Equal-Weight
    May 6, 25 Morgan Stanley
    Equal-Weight
    May 2, 25 HC Wainwright & Co.
    Buy
    May 1, 25 Wells Fargo
    Equal-Weight
    May 1, 25 Evercore ISI Group
    Outperform
    May 1, 25 Citigroup
    Neutral
    Apr 24, 25 Needham
    Hold
    Apr 4, 25 RBC Capital
    Outperform

    Institutional Ownership

    Screeners with BLCO included

    Growing Shares Outstanding
    Mid cap stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    Canadian stocks
    Healthcare sector
    All stocks
    Stocks above analysts price target
    • What is the ticker symbol for Bausch + Lomb Corporation?
    • Does Bausch + Lomb Corporation pay dividends?
    • What sector is Bausch + Lomb Corporation in?
    • What industry is Bausch + Lomb Corporation in?
    • What country is Bausch + Lomb Corporation based in?
    • When did Bausch + Lomb Corporation go public?
    • Is Bausch + Lomb Corporation in the S&P 500?
    • Is Bausch + Lomb Corporation in the NASDAQ 100?
    • Is Bausch + Lomb Corporation in the Dow Jones?
    • When was Bausch + Lomb Corporation's last earnings report?
    • When does Bausch + Lomb Corporation report earnings?

    What is the ticker symbol for Bausch + Lomb Corporation?

    The ticker symbol for Bausch + Lomb Corporation is NYSE:BLCO

    Does Bausch + Lomb Corporation pay dividends?

    No, Bausch + Lomb Corporation does not pay dividends

    What sector is Bausch + Lomb Corporation in?

    Bausch + Lomb Corporation is in the Healthcare sector

    What industry is Bausch + Lomb Corporation in?

    Bausch + Lomb Corporation is in the Medical Instruments & Supplies industry

    What country is Bausch + Lomb Corporation based in?

    Bausch + Lomb Corporation is headquartered in Canada

    When did Bausch + Lomb Corporation go public?

    Bausch + Lomb Corporation's initial public offering (IPO) was on May 6, 2022

    Is Bausch + Lomb Corporation in the S&P 500?

    No, Bausch + Lomb Corporation is not included in the S&P 500 index

    Is Bausch + Lomb Corporation in the NASDAQ 100?

    No, Bausch + Lomb Corporation is not included in the NASDAQ 100 index

    Is Bausch + Lomb Corporation in the Dow Jones?

    No, Bausch + Lomb Corporation is not included in the Dow Jones index

    When was Bausch + Lomb Corporation's last earnings report?

    Bausch + Lomb Corporation's most recent earnings report was on April 30, 2025

    When does Bausch + Lomb Corporation report earnings?

    The next expected earnings date for Bausch + Lomb Corporation is July 30, 2025
    On this page